Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an update.
The board of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited convened its 6th meeting for FY2025, approving several key resolutions. These include the approval of the third quarter financial statements, amendments to the Articles of Association, re-appointment of auditors, and the declaration of an interim dividend of RMB24.50 per ten shares. These decisions are expected to impact the company’s financial transparency, governance, and shareholder returns positively.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products, adhering to both domestic and international accounting standards.
See more insights into 2TZ stock on TipRanks’ Stock Analysis page.